The story of Viagra, and its parent company copyright, presents a challenging case study for investors. At first a blockbuster drug, producing billions in sales , its intellectual property lapse created a deluge of knock-off medications, significantly eroding its position . While some pharmaceutical companies may seek to capitalize on similar condi